Labeler
i3 Pharmaceuticals, LLC NDC Codes
i3 Pharmaceuticals, LLC lists 19 finished drug products in the FDA NDC Directory under NDC labeler code 72319.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Everolimus, Methscopolamine Bromide, Maraviroc, Guanfacine, Ranolazine, Tranexamic Acid, Rifabutin, Clindamycin phosphate, isosorbide dinitrate and hydralazine hydrochloride, Posaconazole, Selegiline Hydrochloride, Ramelteon
- Active ingredients
- Everolimus, Methscopolamine bromide, Maraviroc, Guanfacine hydrochloride, Ranolazine, Tranexamic acid, Rifabutin, Clindamycin phosphate, Isosorbide dinitrate, Hydralazine hydrochloride, Posaconazole, Selegiline hydrochloride
- NDC labeler codes
- 72319
- Strengths
- Everolimus .25 mg/1; Everolimus .5 mg/1; Everolimus .75 mg/1; Everolimus 1 mg/1; Tranexamic acid 650 mg/1; Rifabutin 150 mg/1; Clindamycin phosphate 10 mg/mL; Methscopolamine bromide 2.5 mg/1; Methscopolamine bromide 5 mg/1; Isosorbide dinitrate 20 mg/1; Hydralazine hydrochloride 37.5 mg/1; Posaconazole 100 mg/1; Maraviroc 150 mg/1; Maraviroc 300 mg/1; Guanfacine hydrochloride 1 mg/1; Guanfacine hydrochloride 2 mg/1; Ranolazine 500 mg/1; Ranolazine 1000 mg/1; Selegiline hydrochloride 5 mg/1; Ramelteon 8 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Tablet, Film coated, Extended release, Capsule, Solution, Tablet, Delayed release
- Routes
- Oral, Topical
- Drug classes (FDA established)
- Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Anticholinergic, CCR5 Co-receptor Antagonist, Central alpha-2 Adrenergic Agonist, Anti-anginal, Antifibrinolytic Agent, Rifamycin Antimycobacterial, Lincosamide Antibacterial, Arteriolar Vasodilator, Nitrate Vasodilator, Azole Antifungal, Monoamine Oxidase Inhibitor, Monoamine Oxidase Type B Inhibitor, Melatonin Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 28
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Everolimus | Everolimus .25 mg/1 | TabletOral | 72319-003 | 72319-0003-0272319-0003-60 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | 72319-015 | 72319-0015-0272319-0015-60 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | 72319-016 | 72319-0016-0272319-0016-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | 72319-017 | 72319-0017-0272319-0017-60 | — |
| Tranexamic Acid | Tranexamic acid 650 mg/1 | TabletOral | 72319-028 | 72319-0028-01 | — |
| Rifabutin | Rifabutin 150 mg/1 | CapsuleOral | 72319-010 | 72319-0010-04 | — |
| Clindamycin phosphateclindamycin phosphate topical | Clindamycin phosphate 10 mg/mL | SolutionTopical | 72319-696 | 72319-0696-60 | — |
| Methscopolamine Bromide | Methscopolamine bromide 2.5 mg/1 | TabletOral | 72319-029 | 72319-0029-0472319-0029-06 | — |
| Methscopolamine Bromide | Methscopolamine bromide 5 mg/1 | TabletOral | 72319-030 | 72319-0030-0272319-0030-06 | — |
| isosorbide dinitrate and hydralazine hydrochloride | Isosorbide dinitrate 20 mg/1; Hydralazine hydrochloride 37.5 mg/1 | Tablet, Film coatedOral | 72319-012 | 72319-0012-0372319-0012-18 | — |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | 72319-023 | 72319-0023-02 | — |
| Maraviroc | Maraviroc 150 mg/1 | Tablet, Film coatedOral | 72319-024 | 72319-0024-02 | — |
| Maraviroc | Maraviroc 300 mg/1 | Tablet, Film coatedOral | 72319-025 | 72319-0025-02 | — |
| Guanfacinegaunfacine | Guanfacine hydrochloride 1 mg/1 | TabletOral | 72319-018 | 72319-0018-04 | — |
| Guanfacinegaunfacine | Guanfacine hydrochloride 2 mg/1 | TabletOral | 72319-019 | 72319-0019-04 | — |
| Ranolazine | Ranolazine 500 mg/1 | Tablet, Film coated, Extended releaseOral | 72319-021 | 72319-0021-02 | — |
| Ranolazine | Ranolazine 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 72319-022 | 72319-0022-02 | — |
| Selegiline Hydrochloride | Selegiline hydrochloride 5 mg/1 | TabletOral | 72319-006 | 72319-0006-02 | — |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | 72319-005 | 72319-0005-0172319-0005-0472319-0005-05 | — |
i3 Pharmaceuticals, LLC: common questions
- What is i3 Pharmaceuticals, LLC's NDC labeler code?
- 72319. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for i3 Pharmaceuticals, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.